Industry Ignited Podcast
Industry Ignited is a platform for bold conversations with leaders who are transforming the way business gets done. Each episode spotlights breakthrough stories from the industrial, manufacturing, biotech, chemical, and B2B sectors, giving you an inside look at how top executives, innovators, and changemakers tackle real-world challenges and drive meaningful growth.
Hosted by Dr. Leeanne Aguilar—entrepreneur, executive coach, and marketing strategist—Industry Ignited goes beyond surface-level discussions to uncover the strategies, mindsets, and lessons that fuel leadership at the highest level. From navigating complex operations and scaling companies to rethinking culture and preparing for the future of work, every conversation is designed to inspire, challenge, and equip you with fresh perspectives.
Whether you’re an executive, entrepreneur, or emerging leader, this podcast will spark ideas, expand your vision, and ignite the drive to lead with confidence in today’s evolving business landscape.
Industry Ignited Podcast
Find a Way or Make One: Chris Przybyszewski on Scaling US BIOLOGIC's Vaccine Revolution | Ep. 11
In this Industry Ignited episode, US BIOLOGIC leader Chris Przybyszewski traces a career spanning neuroscience, public health, medical devices, high-tech, and infectious disease—and how it shaped his “translator” leadership style that aligns diverse experts around clear goals, shared definitions, and measurable success. He unpacks lessons from funding science across venture capital, government, and philanthropy—matching missions and ROI while never wasting stakeholders’ time.
Chris spotlights US BIOLOGIC’s breakthrough: orally delivered, thermostable vaccines deployed via backyard pellet stations to immunize reservoir species (like mice) against Lyme disease—an innovation that demanded new chemistry, manufacturing, distribution, and regulatory pathways, plus a deliberate IP “minefield” strategy. Drawing parallels to industrial supply chains, he frames the company as a delivery business optimizing the right antigen to the right species at the right moment, and argues for One Health collaboration across animal, human, environmental, regulatory, and commercial domains.
Looking ahead, he sees AI enabling rapid pathogen detection, antigen selection, regulatory mapping, and development acceleration—while emphasizing that real-world manufacturing and last-mile distribution still decide impact. Anchored by his mantra “find a way or make one,” Chris advises leaders to choose boldly, accept early wrong turns, iterate with discipline, and persevere toward outcomes that protect public health and economies worldwide.